The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
By Ethan Cerami1, Jianjiong Gao, U. Dogrusoz, Benjamin E. Gross, S. O. Sumer, B. A. Aksoy, A. Jacobsen, Caitlin J. Byrne, Michael L. Heuer, E. Larsson and 5 more. Cancer Discovery, 2012
15,324 citations recorded by the source corpus.
Summary The cBio Cancer Genomics Portal (http://cbioportal.org) is an open-access resource for interactive exploration of multidimensional cancer genomics data sets, currently providing access to data from more than 5,000 tumor samples from 20 cancer studies. The cBio Cancer Genomics Portal significantly lowers the barriers between complex genomic data and cancer researchers who want rapid, intuitive, and high-quality access to molecular profiles and clinical attributes from large-scale cancer genomics projects and empowers researchers to translate these rich data sets into biologic insights and clinical applications.
Subfields: Cancer Research, Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/b8d2639696825d163188eb5cea5582c350987b70
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Julia Salzman
- Casey S. Greene
- G. Way
- Phillip A. Sharp
- Matthew Meyerson
- Gad Getz
- Ian O. Ellis
- M. Lawrence
In Genetics
- Marco A. Marra
- Elaine R. Mardis
- Hui Shen
- M. Wiznerowicz
- Patrycja Czerwińska
- Katarzyna Tomczak
- C. Sawyers
- Feixiong Cheng
In Molecular Biology
- Ryuji Hamamoto
- Yusuke Nakamura
- Takehiro Suzuki
- N. Dohmae
- Julia Salzman
- Makoto Nakakido
- Feng Zhang
- Peter W. Laird
Citations in the corpus
- Machine learning and feature selection for drug response prediction in precision oncology applications (2018, background): “Genome-wide genomic profiling approaches based on nextgeneration sequencing (NGS) of thousands of patient tumors have provided “big data” resources to map the disease mechanisms (The Cancer Genome Atlas, TCGA, http:// cancergenome.nih.gov/; International Cancer Genome Consortium, ICGC, https://dcc.i”
- Genomic correlates of clinical outcome in advanced prostate cancer (2019, methodology): “All data from SNV, copy-number, and expression analysis as well as clinical characteristics and outcomes measures (Dataset S1) have been made available in cBioPortal (44) (www.”
- Comprehensive molecular characterization of pheochromocytoma and paraganglioma (2017, background): “Querying a cancer mutation database (Cerami et al., 2012) for CSDE1 returned rare truncating mutations in other tumor types, suggesting that CSDE1 may have a driver role in other cancers.”
- The frequency of Ras mutations in cancer (2020, background): “The Memorial Sloan Kettering Cancer Centre (MSKCC) cBioPortal facilitates meta-analysis of TCGA and 130 other datasets comprising approximately 40,000 samples (38).”
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018, methodology): “All genomic data and clinical attributes per sample can be visualized through the cBioPortal for Cancer Genomics at http://www.cbioportal.org/ ( Cerami et al., 2012).”
- Organoid cultures derived from patients with advanced prostate cancer (2014, neutral): “Genetics data from array-CGH, RNA-seq, and whole-exome sequencing can be analyzed and downloaded from the MSKCC cBioportal (http://www.cbioportal.org) (Cerami et al., 2012).”
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses (2017, methodology): “Multiple public resources such as cBioPortal [25,26], miRGator v 3.0 [29], TANRIC [30], and ISOexpresso [31] aid in the comprehensive analysis of transcriptomic TCGA data.”